Onconova Therapeutics Inc
NASDAQ:TRAW
Onconova Therapeutics Inc
NASDAQ:TRAW
Price:
2.14
USD
-1.83%
Market Closed
Market Cap:
$17.1m
Cash Flow Statement
Cash Flow Statement
Onconova Therapeutics Inc
Onconova Therapeutics Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(24)
|
(137)
|
(141)
|
(167)
|
(140)
|
(18)
|
(13)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
2
|
119
|
119
|
143
|
116
|
(2)
|
(2)
|
|
| Change in Working Capital |
(0)
|
(5)
|
(8)
|
(7)
|
(7)
|
(8)
|
(5)
|
|
| Cash from Operating Activities |
(22)
N/A
|
(23)
-4%
|
(30)
-31%
|
(30)
+2%
|
(31)
-4%
|
(27)
+12%
|
(19)
+28%
|
|
| Investing Cash Flow | ||||||||
| Other Items |
0
|
(4)
|
(4)
|
(4)
|
0
|
0
|
(3)
|
|
| Cash from Investing Activities |
0
N/A
|
(4)
N/A
|
(4)
+0%
|
(4)
+0%
|
0
N/A
|
0
N/A
|
(3)
N/A
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
0
|
14
|
14
|
34
|
34
|
23
|
24
|
|
| Other |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
14
N/A
|
14
+0%
|
34
+143%
|
34
+0%
|
23
-32%
|
23
0%
|
|
| Change in Cash | ||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Net Change in Cash |
(22)
N/A
|
(13)
+43%
|
(20)
-56%
|
1
N/A
|
(0)
N/A
|
(4)
-745%
|
1
N/A
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(22)
N/A
|
(23)
-4%
|
(30)
-31%
|
(30)
+2%
|
(31)
-4%
|
(27)
+12%
|
(19)
+28%
|
|
Switch to:
Switch to:
See Also
Discover More
